identified a germline mutation in GRIM-19 in an individual who presented oncocytic variant of papillary thyroid carcinoma (OV-PTC) on a background of multiple oncocytic cell nodules (16), but the authors did not find loss of heterozygosity for GRIM-19 in tumor tissues. The gene discussed is NDUFA13; the disease is thyroid gland papillary carcinoma.